COMPANY PROFILE

Rubedo Life Sciences

Explore full profile

Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells

Mountain View, United StatesFounded 2018Biotech & Life Sciences

Valuation $100–250M Last recorded · 2024

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Rubedo Life Sciences

Rubedo Life Sciences is a pioneering company in the field of longevity, focusing on developing therapeutics aimed at combating age-related diseases and extending healthy lifespan. The company operates primarily in the life sciences market and serves clients ranging from individual patients to large healthcare institutions. Rubedo Life Sciences employs a business model that combines cutting-edge research with clinical applications, generating revenue through the development and commercialization of novel therapies. The company leverages its expertise in oncodermatology and skin health to advance cancer care and improve the quality of life for patients. Located in Silicon Valley, California, Rubedo Life Sciences is led by a team of renowned scientists and entrepreneurs with a deep passion for longevity science.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Mountain View, United States
Employees: 34
Open positions: 1
Dealroom signal: 74.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Longevity, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Apr 2024	$40M	$160M	LongeVC · Hevolution · Cerigo Investments · Khosla Ventures	↗
SERIES AOther financing	Oct 2023	$0	—	Undisclosed	—

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Rubedo Life Sciences website traffic

Latest recorded traffic for Rubedo Life Sciences is 3.3K monthly website visits, up 37.5% over the last three months. Rubedo Life Sciences's team declined 5.6% over the past year.

Latest monthly visits3.3K 3-month web change+37.5% 1-year team growth-5.6%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

RA-II/SRA, Histology TechnicianSunnyvale, Santa Clara County, California, United States · Other · Aug 1, 2026 CIRM CALPOLY – MASTER INTERNSHIP – 9 MONTHS – SALARIEDSunnyvale, Santa Clara County, California, United States · Other · Aug 1, 2026 RA-II/SRA, Digital Pathology Image AnalysisSunnyvale, Santa Clara County, California, United States · Other · Aug 1, 2026 Research Associate, ImmunohistochemistryMountain View, CA · Other · Jun 11, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CRCell Biopeutics ResourcesCommercializing mesenchymal stem cell therapeutics and cosmetics	Kuala Lumpur, Malaysia	Operational	10	$1.1M	$4.4M
FBFoundry BioSciencesProtein engineering with AI to extend longevity and elevate quality of life	Boston, United States	Operational
GBGalilei BiosciencesDrug development company targeting a central regulator of DNA damage repair, as well as glucose and lipid metabolism, driving metabolic health and human longevity	Cambridge, United States	Operational
EBEntact BioA preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins	Watertown, United States	Operational
OTOviva TherapeuticsA movement to improve women's experience of aging through biomedical research, development and advocacy	New York City, United States	Acquired
IMImmunisA private biotechnology company focused on the development of treatments for age-related and disease-related immune deficits	Irvine, United States	Operational
CECellVoyantAn AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases	Bristol, United Kingdom	Operational
VTVasa TherapeuticsPrecision medicine for heart failure and healthy aging	Encinitas, United States	Operational